Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 438

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1C
Chunk 438
---
 date, our disclosure controls and procedures were effective.

Management’s
Annual Report on Internal Control Over Financial Reporting

Our
management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined
in Exchange Act Rule 13a-15(f). Internal control over financial reporting is a process designed under the supervision and with the participation
of our management, including our principal executive officer and principal financial officer, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with
U.S. GAAP. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined
to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

A
material weakness is a deficiency, or a combination of deficiencies, in internal controls over financial reporting such that it is reasonably
possible that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.
The material weakness previously identified was due to (i) the design and implementation of appropriate segregation of duties to separate
the roles of authorizing, initiating, and recording transactions or reviewing transactions for the completeness and accuracy of contracts
with financial reporting implications and (ii) the Company lacking sufficient appropriate accounting and reporting knowledge to effectively
perform review controls surrounding technical accounting matters. As of December 31, 2024, our principal executive officer and principal
financial officer, conducted an evaluation of the effectiveness of our internal control over financial reporting based on the Committee
of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework - 2013. Based on this assessment and
implementation of our remediation plans, management concluded that, as of December 31, 2024, our internal controls over financial reporting
were effective.

This
Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm regarding internal
control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting
firm pursuant to the exemption provided to issuers that are not “large accelerated filers” nor “accelerated filers”
under the Dodd-Frank Wall Street Reform and Consumer Protection Act as well as issuers that are “emerging growth companies”
under the JOBS Act.

-35-

Changes
in Internal Control Over Financial Reporting

There
were no changes in our internal control over financial reporting that occurred during the year ended December